IMTX
NASDAQ · Biotechnology
Immatics Nv
$8.62
-0.20 (-2.27%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+796.2% upside
Low Target
$52.47
Average Target
$77.25
High Target
$103.74
Current Price
$8.62
Current
$8.62
$8.62
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Scenario Analysis
Bear Case
$52.47
508.7%
Low target
Base Case
$77.25
+796.2%
Avg target
Bull Case
$103.74
+1,103.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$12.41
-30.5% from high
52-Week Low
$5.92
+45.7% from low
Target vs 52W High
$77.25
+522.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |